dietary sources include oily fish, algae oil, and krill oil)
Common clinical goals for BPC-157 include: Supporting soft-tissue healing (tendons, ligaments, muscles, and fascia) after injury or overuse Promoting post-surgical recovery and tissue regeneration Reducing inflammation and associated pain in joints and musculoskeletal conditions Supporting gut lining integrity and symptoms related to gastric ulcers, IBS, or leaky gut Assisting recovery from sports-related injuries and enhancing exercise recovery Supporting blood flow to injured tissues to aid repair Adjunctive support for chronic pain related to tissue or nerve injury Addressing Common Misconceptions and Questions Surrounding BPC-157 Online discussions often include myths that can cloud understanding
More serious side effects, though rare, can include Stevens-Johnson syndrome, toxic epidermal necrolysis, anaphylactic shock, and liver dysfunction
In addition, GCs inhibit the proliferation of osteoblast precursors via suppression of intracellular mitogenic signaling pathways, specifically mitogen-activated protein kinase (MAPK) signaling [25, 26]